Trending News
News
News
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients.
News
deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
Findings offer promising target for drugs to better regulate calcium metabolism, are integrated into deCODEme™.
News
deCODE-led Mega-study Finds new Genetic Clues to Causes of Schizophrenia
Findings expand knowledge of the biology of the disease and provide potential new drug targets.
News
Scientists Kill Cancer Cells With "Trojan Horse"
New therapy combats cancer, using a bacterially-derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills it with chemotherapy drugs.
News
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway acquires worldwide commercial rights for three investigational dermatological molecules from Pfizer.
News
Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
Maxygen to contribute R&D operations and assets to newly-formed joint venture; Astellas to be granted 3-year option to acquire joint venture.
News
European Centre of Excellence for Mouse Biology Celebrates its 10th Anniversary
Scientists investigating basic research topics have generated mouse models of over 20 different human diseases over the past 10 years.
News
Targeting Helpers of Heat Shock Proteins Could Help Treat Cancer, Cardiovascular Disease
MCG researchers are working to explain how Hsp90 gets steroid receptors into shape to use hormones for hormone-driven cancers.
News
febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
febit technology is claimed to enable the conversion of new sequence data into biochips for Next-Generation Sequencing within days.
News
Drug Discovery Unit, University of Dundee, and DNDi Collaborate to Identify Drug Candidates to Treat Visceral Leishmaniasis
The £1.8m collaboration focuses on the discovery and development of affordable and effective therapies for the disease.
Advertisement